Longitude Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
183
- Portfolio
-
34
- Exits
-
118
Longitude Capital General Information
Company Description
Founded in 1997, Longitude Capital is a venture capital investment firm based in Menlo Park, California. The firm seeks to invest in biotechnology, medical technology, and health solutions sectors.
Business Details
Website
www.longitudecapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 2740 Sand Hill Road
- 2nd Floor
- Menlo Park, CA 94025
- United States
Longitude Capital Investments (183)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| North Immunology | 17-Sep-2026 | PIPE | Biotechnology | Generating Revenue | ||
| Entera Bio | 28-Jul-2026 | Drug Delivery | Generating Revenue | |||
| Quanta Therapeutics | 24-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Infinant Health | 08-Jun-2026 | Drug Discovery | Clinical Trials - General | |||
| Endogenex | 25-Mar-2026 | Therapeutic Devices | Clinical Trials - General | |||
| Ventaris Surgical | 02-Mar-2026 | Surgical Devices | Clinical Trials - General | |||
| cAMPfield Therapeutics | 30-Jan-2026 | Drug Delivery | Clinical Trials - Phase 3 | |||
| AirNexis Therapeutics | 09-Jan-2026 | Biotechnology | Clinical Trials - Phase 1 | |||
| Vera Therapeutics | 14-Oct-2025 | PIPE | Biotechnology | Generating Revenue/Not Profitable | ||
| VeraDermics | 10-Oct-2025 | Later Stage VC | Drug Discovery | Generating Revenue |
Longitude Capital Exits (118)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Rapid Micro Biosystems | 20-May-2026 | Public Investment 2nd Offering | |
| Mobia Medical | 08-May-2026 | ||
| VeraDermics | 29-Apr-2026 | ||
| Zenas BioPharma | 26-Mar-2026 | ||
| VeraDermics | 03-Feb-2026 | ||
| Nalu Medical | 27-Jan-2026 | ||
| Vera Therapeutics | 11-Dec-2025 | ||
| Lexeo Therapeutics | 16-Oct-2025 | ||
| Bolt Medical | 01-Apr-2025 | Merger/Acquisition | |
| Kestra Medical Technologies | 06-Mar-2025 | IPO |
Longitude Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Longitude Capital Investments by Industry, Year, and Region
Longitude Capital Co-Investors (200)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 9 |
|
|
||
| OrbiMed |
|
|
|||
| Frazier Healthcare Partners |
|
|
|||
| BVF Partners |
|
|
|||
| Novo Holdings |
|
|
Longitude Capital FAQs
-
What is Longitude Capital?
Founded in 1997, Longitude Capital is a venture capital investment firm based in Menlo Park, California.
-
When was Longitude Capital founded?
Longitude Capital was founded in 1997.
-
Where is Longitude Capital headquartered?
Longitude Capital is headquartered in Menlo Park, CA.
-
What is Longitude Capital's total asset value?
Longitude Capital has around in total assets under management.
-
How many investments has Longitude Capital made?
Longitude Capital has made 183 investments.
-
What has Longitude Capital invested in?
Longitude Capital has made numerous investments in companies like North Immunology, Entera Bio, and Quanta Therapeutics within the Biotechnology, Drug Delivery, and Drug Discovery industries.
-
What has Longitude Capital invested in recently?
Longitude Capital's latest investment was on 17-Sep-2026 in North Immunology, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process